All are selective serotonin reuptake inhibitor except:
First, I need to recall the core concept. SSRIs are a class of antidepressants that work by inhibiting the reuptake of serotonin in the synaptic cleft, increasing its availability. Common examples include fluoxetine, sertraline, paroxetine, escitalopram, and citalopram. However, some drugs like venlafaxine or bupropion are not SSRIs. Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI), and bupropion is a norepinephrine-dopamine reuptake inhibitor (NDRI).
Now, the correct answer explanation should mention that the incorrect option is not an SSRI. For example, if the options included venlafaxine, then the explanation would state that venlafaxine is an SNRI. Each wrong option should be addressed. For instance, if another option was fluoxetine, that's an SSRI and thus incorrect as the answer.
The clinical pearl here is to remember the common SSRIs and differentiate them from other classes. A mnemonic like "Serotonin Selective Serotonin Reuptake Inhibitors: F, S, P, E, C" (Fluoxetine, Sertraline, Paroxetine, Escitalopram, Citalopram) might help. Also, knowing that SNRIs and other antidepressants like tricyclics or MAOIs are different classes.
I need to structure the explanation into the required sections. For each wrong option, explain why it's incorrect. For example, if the options were A: Fluoxetine (SSRI), B: Venlafaxine (SNRI), C: Paroxetine (SSRI), D: Citalopram (SSRI), then the correct answer is B. The explanation would state that venlafaxine inhibits both serotonin and norepinephrine reuptake.
I should check for any possible errors. Make sure the terms are accurate and the explanations are concise. Also, ensure the clinical pearl is memorable and relevant to the exam. Maybe mention that SNRIs are a common trap in such questions.
**Core Concept**
Selective serotonin reuptake inhibitors (SSRIs) inhibit the reuptake of serotonin (5-HT) via the **sodium-dependent serotonin transporter (SERT)**, enhancing serotonergic neurotransmission. They are first-line for depression and anxiety disorders. Non-SSRIs may target other neurotransmitters (e.g., norepinephrine) or mechanisms.
**Why the Correct Answer is Right**
The non-SSRI option likely inhibits reuptake of another neurotransmitter or acts via a different mechanism. For example, **Venlafaxine** (an SNRI) inhibits both serotonin and norepinephrine reuptake, making it pharmacologically distinct from SSRIs. This dual action increases its use in treatment-resistant depression but differentiates it from SSRIs.
**Why Each Wrong Option is Incorrect**
**Option